Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 2,098 Jul 29 – Oct 26, 2026
- Disclosed funding
- $144.3B 1451 disclosed amounts
- Median round
- $10.1M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| U UmeCompany profile Ume provides technology and financing infrastructure that lets Brazilian businesses offer consumer credit under their own brands. Ume provides technology and financing infrastructure that lets Brazilian businesses offer consumer credit under their own brands. | R$500M | FIDC credit-portfolio financingUndisclosed | Fintech | Brazil | Investors | |
| AA Amanda AICompany profile Amanda AI helps marketing teams allocate advertising budgets and manage campaigns across Google, Meta and Bing. Amanda AI helps marketing teams allocate advertising budgets and manage campaigns across Google, Meta and Bing. | SEK 10M | Shareholder financingUndisclosed | Enterprise software | Sweden | Investors | |
| K KalzCompany profile Kalz develops a process that binds CO2 into industrial residues to produce materials for cement and concrete. Kalz develops a process that binds CO2 into industrial residues to produce materials for cement and concrete. | Undisclosed | Pre-seed | Climate tech | Germany | Investors | |
| TH Thrive HoldingsCompany profile Acquires traditional accounting and IT services firms and rebuilds them using AI Acquires traditional accounting and IT services firms and rebuilds them using AI | >$2B | Growth | AI | United States | Investors | |
MindgardCompany profile Mindgard helps enterprise security teams find and address vulnerabilities in AI models, applications and agents. Mindgard helps enterprise security teams find and address vulnerabilities in AI models, applications and agents. | $30M | Series A | Cybersecurity | United Kingdom | Investors | |
| VV Versa VascularCompany profile Develops a transcatheter device for minimally invasive tricuspid valve repair Develops a transcatheter device for minimally invasive tricuspid valve repair | $42M | Series CSeries C+ | Healthtech | United States | Investors | |
| NN Nomade NationCompany profile Nomade Nation designs and manufactures campervans for travel and mobile living. Nomade Nation designs and manufactures campervans for travel and mobile living. | €1.8M | Funding roundUndisclosed | Mobility | Spain | Investors | |
AquaNabCompany profile AquaNab develops nanoantibody-based treatments for fish diseases, starting with sea lice in salmon farming. AquaNab develops nanoantibody-based treatments for fish diseases, starting with sea lice in salmon farming. | Undisclosed | Undisclosed | Biotech | Germany | Investors | |
| C CobiCompany profile Cobi helps product and growth teams interpret customer behaviour and choose relevant actions. Cobi helps product and growth teams interpret customer behaviour and choose relevant actions. | $1M | Pre-seed | AI | United Arab Emirates | Investors | |
| HG HOUF GamesCompany profile HOUF Games creates board games and collectible cards built around original characters, themes and game worlds. HOUF Games creates board games and collectible cards built around original characters, themes and game worlds. | Undisclosed | Pre-seed | Media & gaming | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 29, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
71rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
46rounds18led - 3Khosla Ventures
Arda Industries, Tolan
33rounds10led - 4Sequoia Capital
Warhound, Whop, Blacksmith
31rounds11led - 5General Catalyst
Provision Labs, Tractian, Legora
30rounds11led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →